CIK 0000021665
- Large accelerated filer
COLGATE PALMOLIVE CO
Sign in to watch- Ticker
- CL
- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 131815595
- Phone
- +1 212-310-2000
- Business address
- 300 PARK AVE, NEW YORK, NY, 10022
- Former names
- COLGATE PALMOLIVE CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,027,828
- in 6 filings
Net −$8,027,828. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Tsourapas Panagiotis −$2.9M COO, CD, EMEA, APac, Skin sold 77% of stake
- Hazlin John −$2.3M Chief Growth Officer sold 46% of stake
- Wallace Noel R. −$2.0M Chairman, President & CEO sold 5% of stake
- NORRINGTON LORRIE M −$414K Director sold 9% of stake
- Malcolm Gregory −$402K EVP and Controller sold 29% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | BILBREY JOHN P Director | Grant or award | +271 | $87.42 | $24K | 40,725 |
| 2026-07-01 | BILBREY JOHN P Director | Grant or award | +265 | $89.45 | $24K | 40,229 |
| 2026-05-11 | BILBREY JOHN P Director | Grant or award | +2,075 | 39,820 | ||
| 2026-05-11 | BILBREY JOHN P Director | Grant or award · Stock Option (Right to Buy) | +2,424 | 2,424 | ||
| 2026-04-01 | BILBREY JOHN P Director | Grant or award | +266 | $89.05 | $24K | 37,665 |
| 2026-01-02 | BILBREY JOHN P Director | Grant or award | +301 | $78.66 | $24K | 37,195 |
| 2025-10-01 | BILBREY JOHN P Director | Grant or award | +289 | $82.13 | $24K | 36,658 |
| 2025-07-01 | BILBREY JOHN P Director | Grant or award | +264 | $89.91 | $24K | 36,156 |
| 2025-05-12 | BILBREY JOHN P Director | Grant or award | +2,019 | 35,768 | ||
| 2025-05-12 | BILBREY JOHN P Director | Grant or award · Stock Option (Right to Buy) | +2,272 | 2,272 | ||
| 2025-04-01 | BILBREY JOHN P Director | Grant or award | +231 | $91.99 | $21K | 33,688 |
| 2025-01-02 | BILBREY JOHN P Director | Grant or award | +228 | $93.18 | $21K | 33,273 |
| 2024-10-01 | BILBREY JOHN P Director | Grant or award | +201 | $105.24 | $21K | 32,879 |
| 2024-07-01 | BILBREY JOHN P Director | Grant or award | +222 | $95.61 | $21K | 32,521 |
| 2024-05-13 | BILBREY JOHN P Director | Grant or award | +1,905 | 32,198 | ||
| 2024-05-13 | BILBREY JOHN P Director | Grant or award · Stock Option (Right to Buy) | +2,201 | 2,201 | ||
| 2024-05-01 | BILBREY JOHN P Director | Option exercise | +6,329 | $62.04 | $393K | 36,565 |
| 2024-05-01 | BILBREY JOHN P Director | Sale | −6,329 | $91.59 | $580K | 30,236 |
| 2024-05-01 | BILBREY JOHN P Director | Option exercise · Stock Option (Right to Buy) | −6,329 | 0 | ||
| 2024-04-01 | BILBREY JOHN P Director | Grant or award | +240 | $88.36 | $21K | 30,236 |
Page 1 of 2 · 21 trades